Skip to main content

Reply to comment

Myxoma Virus: From Rabbits to Cancer

April 15, 2008 by PhageDude

More than half a million individuals in the US died in 2004 from cancer and more than 10.8 million Americans are living with the disease.(CDC 2008) The number of cancer deaths each year continues to decline, due to advances in medical technologies. With the advent of a cervical cancer vaccine,Gardasil this number promises to continue to drop dramatically. Furthermore, there are new treatments in development that promise to revolutionize the effective treatment of cancer. One of these, which I am currently fascinated by, is oncolytic virotherapy.

Oncolytic virotherapy is the use of live viruses to kill malignant cells in situ. The use of viruses holds potential to not only be a direct treatment of cancer, but also studies of viruses with cancer cell tropisms may help in the development of other treatments and vaccines.

Myxoma virus has a historical place in world history as the failed attempt to control feral rabbit populations in Austrailia. However, it holds great promise as an oncolytic agent. For currently unknown reasons, myxoma virus has a distinct tropism for European Rabbits and for cancer cells. Read more about myxoma virus as an oncolytic over at Blogging for Bacteriophages.

Reply

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <p> <sub> <blockquote> <br> <hspace> <img> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <width> <height> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes